Brief: Fate Therapeutics To Present Clinical And Preclinical Data For Ipsc Product Platform At The 2022 Ash Annual Meeting
03/11/2022 14:03
Nov 3 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS TO PRESENT CLINICAL AND PRECLINICAL DATA
FOR
IPSC PRODUCT PLATFORM AT THE 2022 ASH ANNUAL MEETING
Source text for Eikon: ID:nGNX8q421V
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview